hotspot -WSS

hotspot

author：leisure time 2025-08-12 08:25:11 - browse：8

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： How CRISPR works, explained in two minutes

WSS

Trump used to be more articulate. What could explain the change?

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

New weight loss drugs vying to be the next Wegovy or Mounjaro

Slovenia has suffered its worst

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

A common UTI test for kids haunts adults as a traumatic 'nightmare'

leisure time

hotspot

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Restaurant meals are packed with calories, and we still keep eating them

Apple is now the first public company to be valued at $3 trillion

FDA approves updated Covid vaccines

Anesthesiologist group: stop taking Ozempic before surgery

Pennsylvania man bitten on the head by bear during attack in his garage

How to save PrEP access — and even expand it

Private equity could exacerbate cardiology's overuse problem, experts fear

Peter Hotez and the public health issue of online harassment

Doctors are clamoring for more clarity on Paxlovid prescribing

hotspot

Sage considers ways to reduce costs following FDA rejection

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Doctors push to include dialysis machines in emergency stockpile

Feed a cold, starve a fever? Here’s what science says

Hospitals consider fixing cancer drug shortages on their own

St. Louis police protesters begin picking up checks in $4.9 million settlement

entertainment

knowledge

Wikipedia

Wikipedia